Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $136.17M | 17.80% | 13.80% | 15.12% | 20.30% | 0.25 | 8.94 | 100.00% | 30.70% | 30.71% | ||
| HTFL | HEARTFLOW INC | $2.40B | N/A | N/A | N/A | N/A | 0.43 | 8.66 | N/A | N/A | N/A | ||
| FBRX | FORTE BIOSCIENCES INC | $401.36M | -75.60% | -65.90% | -61.53% | -3,473.20% | 0.15 | 7.34 | N/A | N/A | N/A | ||
| W | WAYFAIR INC | $11.85B | N/A | -9.80% | -25.41% | -6.20% | -2.13 | 0.74 | 30.20% | -2.70% | -1.79% | ||
| NBP | NOVABRIDGE BIOSCIENCES | $394.49M | -11.50% | -10.80% | -9.39% | -26.90% | 0.07 | 14.47 | N/A | N/A | N/A | ||
| CNTX | CONTEXT THERAPEUTICS INC | $211.32M | -30.90% | -29.60% | -36.12% | 8,256.50% | 0.08 | 13.10 | N/A | N/A | N/A | ||
| LAKE | LAKELAND INDUSTRIES INC | $93.84M | -26.30% | -17.10% | -15.57% | -17.60% | 0.64 | 3.83 | 34.80% | -19.40% | -14.75% | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.49B | -31.20% | -26.80% | -32.51% | -35.40% | 0.11 | 10.91 | N/A | N/A | N/A | ||
| BETA | BETA TECHNOLOGIES INC | $4.13B | N/A | N/A | N/A | N/A | 0.35 | 10.43 | N/A | N/A | N/A | ||
| ZYME | ZYMEWORKS INC | $1.73B | -19.20% | -15.00% | -15.78% | -19.20% | 0.24 | 6.94 | 100.00% | -47.20% | -41.69% | ||
| CSTL | CASTLE BIOSCIENCES INC | $1.02B | -2.70% | -2.30% | -3.70% | -5.70% | 0.21 | 6.47 | 79.90% | -3.60% | -5.46% | ||
| LBRX | LB PHARMACEUTICALS INC | $535.58M | N/A | N/A | N/A | N/A | 0.03 | 47.60 | N/A | N/A | N/A | ||
| CEVA | CEVA INC | $496.45M | -4.20% | -3.70% | -2.04% | -2.80% | 0.14 | 8.68 | 87.20% | -10.50% | -5.34% | ||
| ZGN | ERMENEGILDO ZEGNA NV | $2.47B | 5.70% | 1.80% | 7.29% | 6.10% | 2.01 | 1.42 | 67.10% | 2.60% | 7.33% | ||
| MARA | MARA HOLDINGS INC | $3.13B | 20.80% | 12.30% | 13.98% | 12.70% | 0.77 | 2.09 | 26.40% | 100.80% | 132.24% | ||
| KRRO | KORRO BIO INC | $115.46M | -68.90% | -45.90% | -60.11% | -49.60% | 0.63 | 6.71 | 100.00% | -1,199.50% | -1,198.11% | ||
| ABVX | ABIVAX SA | $8.28B | N/A | N/A | N/A | N/A | 0.28 | 7.86 | N/A | N/A | N/A | ||
| AKA | AKA BRANDS HOLDING CORP | $117.71M | -23.20% | -6.60% | -3.72% | -3.40% | 2.74 | 1.35 | 57.40% | -4.40% | -1.90% | ||
| CHYM | CHIME FINANCIAL INC | $8.14B | N/A | N/A | N/A | N/A | 0.36 | 4.94 | N/A | N/A | N/A | ||
| TYRA | TYRA BIOSCIENCES INC | $1.64B | -35.80% | -33.60% | -39.05% | -47.60% | 0.08 | 17.71 | N/A | N/A | N/A | ||
| CARL | CARLSMED INC | $306.08M | N/A | N/A | N/A | N/A | 0.26 | 12.03 | N/A | N/A | N/A | ||
| CLFD | CLEARFIELD INC | $421.68M | -3.10% | -2.60% | -2.11% | -2.20% | 0.20 | 5.42 | 33.70% | -5.40% | -3.79% | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $175.82M | 7.90% | 5.10% | 10.31% | 72.20% | 0.59 | 1.25 | 85.00% | 10.50% | 13.43% | ||
| IMTX | IMMATICS NV | $1.14B | -23.30% | -19.10% | -26.21% | -40.90% | 0.24 | 7.36 | 100.00% | -136.70% | -141.11% | ||
| CGTX | COGNITION THERAPEUTICS INC | $90.92M | -150.10% | -95.90% | -76.14% | 728.50% | 0.19 | 6.45 | N/A | N/A | N/A | ||
| CRVO | CERVOMED INC | $43.21M | -76.80% | -68.10% | -98.36% | -106.60% | 0.18 | 6.66 | 100.00% | -415.40% | -415.36% | ||
| KYMR | KYMERA THERAPEUTICS INC | $5.59B | -33.40% | -28.60% | -28.61% | -33.60% | 0.17 | 7.38 | 100.00% | -674.80% | -674.04% | ||
| SLDB | SOLID BIOSCIENCES INC | $507.97M | -73.60% | -60.00% | -70.12% | -112.70% | 0.26 | 6.74 | N/A | N/A | N/A | ||
| TERN | TERNS PHARMACEUTICALS INC | $3.25B | -30.00% | -28.50% | -32.91% | -55.60% | 0.06 | 19.52 | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $7.24B | -21.10% | -19.70% | -22.12% | -22.30% | 0.10 | 8.83 | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $728.41M | -42.10% | -39.80% | -48.01% | -49.30% | 0.07 | 10.45 | N/A | N/A | N/A | ||
| GHI | GREYSTONE HOUSING IMPACT INVESTORS LP | $182.29M | 2.90% | 0.50% | N/A | 2.60% | 3.77 | N/A | 100.00% | 9.00% | 70.69% | ||
| GHRS | GH RESEARCH PLC | $963.94M | -15.80% | -15.30% | -14.53% | -71.20% | 0.04 | 28.32 | N/A | N/A | N/A | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $1.81B | -41.50% | -37.60% | -48.25% | -50.60% | 0.15 | 8.03 | N/A | N/A | N/A | ||
| HELP | CYBIN INC | $146.49M | -51.80% | -44.00% | -59.24% | -307.40% | 0.30 | 8.58 | N/A | N/A | N/A | ||
| SGMT | SAGIMET BIOSCIENCES INC | $197.73M | -42.40% | -40.30% | -48.36% | -70.10% | 0.08 | 13.06 | N/A | N/A | N/A | ||
| NTSK | NETSKOPE INC | $5.16B | N/A | N/A | N/A | N/A | 10.36 | 2.33 | N/A | N/A | N/A | ||
| USAR | USA RARE EARTH INC | $3.12B | N/A | -156.60% | -82.59% | -517.00% | -6.09 | 16.51 | N/A | N/A | N/A | ||
| MBX | MBX BIOSCIENCES INC | $1.72B | -29.30% | -28.10% | -20.75% | -42.40% | 0.03 | 32.96 | N/A | N/A | N/A | ||
| LUCK | LUCKY STRIKE ENTERTAINMENT CORP | $1.01B | N/A | -2.90% | 6.26% | 3.70% | -9.62 | 0.69 | 35.50% | -7.60% | 15.35% | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.27B | 8.30% | 5.10% | 5.51% | 9.80% | 0.87 | 6.54 | 100.00% | 11.50% | 12.09% | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $1.55B | -25.80% | -20.20% | -20.82% | -28.70% | 0.12 | 8.29 | N/A | N/A | N/A | ||
| BNTX | BIONTECH SE | $26.15B | -3.00% | -2.60% | -2.32% | -5.00% | 0.16 | 7.12 | 82.50% | -18.10% | -14.07% | ||
| LXEO | LEXEO THERAPEUTICS INC | $530.62M | -90.50% | -70.90% | -82.85% | -112.40% | 0.19 | 7.40 | N/A | N/A | N/A | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.65B | N/A | N/A | N/A | N/A | 0.19 | 4.92 | N/A | N/A | N/A | ||
| OKLO | OKLO INC | $10.66B | 68.30% | 64.60% | -6.30% | -19.30% | 0.03 | 67.51 | N/A | N/A | N/A | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.16M | -144.40% | -71.70% | -109.10% | -184.00% | 1.69 | 3.87 | N/A | N/A | N/A | ||
| ORIC | ORIC PHARMACEUTICALS INC | $1.03B | -45.30% | -41.80% | -32.91% | -55.20% | 0.06 | 14.65 | N/A | N/A | N/A | ||
| UPB | UPSTREAM BIO INC | $1.59B | -28.80% | -28.10% | -32.23% | -40.80% | 0.03 | 32.67 | 100.00% | -4,386.40% | -4,366.77% | ||
| KYTX | KYVERNA THERAPEUTICS INC | $333.73M | -77.90% | -65.80% | -104.98% | -103.60% | 0.23 | 5.16 | N/A | N/A | N/A | ||
| ACRV | ACRIVON THERAPEUTICS INC | $53.33M | -53.70% | -48.30% | -62.69% | -69.00% | 0.13 | 8.75 | N/A | N/A | N/A | ||
| RAPP | RAPPORT THERAPEUTICS INC | $1.26B | -28.60% | -27.20% | -18.75% | -38.90% | 0.05 | 36.37 | N/A | N/A | N/A | ||
| CBIO | CRESCENT BIOPHARMA INC | $134.90M | -84.60% | -71.60% | -46.53% | 693.40% | 0.19 | 6.63 | N/A | N/A | N/A | ||
| APGE | APOGEE THERAPEUTICS INC | $4.43B | -39.10% | -36.90% | -42.80% | -46.30% | 0.07 | 15.86 | N/A | N/A | N/A | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.92B | -15.50% | -14.40% | -14.34% | -17.40% | 0.09 | 12.44 | 100.00% | -74.80% | -74.82% | ||
| NRIX | NURIX THERAPEUTICS INC | $1.70B | -57.50% | -43.80% | -43.83% | -59.10% | 0.28 | 7.02 | 100.00% | -314.90% | -314.00% | ||
| NAVN | NAVAN INC | $2.75B | N/A | N/A | N/A | N/A | 0.47 | 4.49 | N/A | N/A | N/A | ||
| PEPG | PEPGEN INC | $337.55M | -84.10% | -65.60% | -53.08% | -125.70% | 0.17 | 13.15 | N/A | N/A | N/A | ||
| AIRG | AIRGAIN INC | $55.96M | -19.70% | -12.80% | -17.52% | -38.30% | 0.53 | 2.13 | 42.90% | -10.90% | -10.79% | ||
| ANRO | ALTO NEUROSCIENCE INC | $466.00M | -47.40% | -38.10% | -43.51% | -245.30% | 0.32 | 15.42 | N/A | N/A | N/A | ||
| TRVI | TREVI THERAPEUTICS INC | $1.47B | -31.20% | -29.30% | -24.11% | -50.10% | 0.05 | 21.93 | N/A | N/A | N/A | ||
| CYRX | CRYOPORT INC | $465.64M | 13.00% | 8.10% | 9.50% | 11.80% | 0.51 | 15.77 | 46.60% | 31.30% | 37.13% | ||
| IMRX | IMMUNEERING CORP | $306.06M | -73.50% | -65.00% | -26.99% | -1,472.40% | 0.06 | 24.00 | N/A | N/A | N/A | ||
| CTMX | CYTOMX THERAPEUTICS INC | $960.70M | 44.50% | 20.30% | 24.11% | 60.40% | 0.47 | 3.64 | 100.00% | 24.70% | 24.87% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.